Offers Invited
Hilco are pleased to offer for sale the business assets of a University of Oxford biotech spinout that researches and develops protective vaccines against antimicrobial resistance (AMR) bacteria leveraging a proprietary and novel synthetic biology platform.
Intellectual Property Assets – The established Brand, patents, trademarks, domain names and website content
Laboratory Equipment – A range of laboratory equipment including incubators, image cytometers and cell imaging instruments
Technology Licence – The right to pursue a recently terminated licence agreement which provided technology to produce genome-free bacterial cells
On receipt of a signed non-disclosure agreement (NDA) access will be provided to a virtual data room housing additional information. To access the NDA please click the link, sign and return via email to nhughes@hilcoglobaladvisors.co.uk.
No warranties, express or implied, are provided in relation to any information or statements made in connection to this opportunity. The information contained herein, and within the project dataroom, has not been verified by Hilco and prospective purchasers must undertake their own due diligence to satisfy themselves as to the accuracy of all such information and any statements made. Hilco acts as agent for the Vendor who offers for sale only such right, title and interest the Company possesses in the assets.
Senior Director
London Office
